Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2831

1.

Recommendations for best practices in the treatment of Alzheimer's disease in managed care.

Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, Leifer B, Mills C, Minkoff N, Orland B, Reichman WE, Salloway S.

Am J Geriatr Pharmacother. 2006;4 Suppl A:S9-S24; quiz S25-S28.

PMID:
17157793
[PubMed - indexed for MEDLINE]
3.

The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.

Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP.

Postgrad Med. 2005 Jan;Spec No:6-22.

PMID:
17203561
[PubMed - indexed for MEDLINE]
5.

Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.

Standridge JB.

Clin Ther. 2004 May;26(5):615-30. Review.

PMID:
15220008
[PubMed - indexed for MEDLINE]
6.

Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.

Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S.

Am J Manag Care. 2001 Aug;7(8):809-18. Review.

PMID:
11519239
[PubMed - indexed for MEDLINE]
Free Article
7.

Optimizing coding and reimbursement to improve management of Alzheimer's disease and related dementias.

Fillit H, Geldmacher DS, Welter RT, Maslow K, Fraser M.

J Am Geriatr Soc. 2002 Nov;50(11):1871-8. Review.

PMID:
12410910
[PubMed - indexed for MEDLINE]
8.

Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational study.

Gil P, Ayuso JL, Marey JM, Antón M, Quilo CG.

Clin Drug Investig. 2008;28(7):429-37.

PMID:
18544003
[PubMed - indexed for MEDLINE]
9.

Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia.

Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctôt K, Morgan D, Thorpe L.

CMAJ. 2008 Oct 7;179(8):787-93. doi: 10.1503/cmaj.070803. Review. Erratum in: CMAJ. 2008 Oct 21;179(9):932.

PMID:
18838454
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.

Haywood WM, Mukaetova-Ladinska EB.

Am J Geriatr Pharmacother. 2006 Sep;4(3):273-86. Review.

PMID:
17062329
[PubMed - indexed for MEDLINE]
11.

Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries.

Gruber-Baldini AL, Stuart B, Zuckerman IH, Simoni-Wastila L, Miller R.

J Am Geriatr Soc. 2007 Oct;55(10):1508-16. Epub 2007 Aug 28. Erratum in: J Am Geriatr Soc. 2007 Oct;55(10):1697.

PMID:
17727648
[PubMed - indexed for MEDLINE]
12.

Cognitive pharmacotherapy of Alzheimer's disease and other dementias.

Herrmann N.

Can J Psychiatry. 2002 Oct;47(8):715-22. Review.

PMID:
12420649
[PubMed - indexed for MEDLINE]
13.

Practical treatment strategies for patients with Alzheimer's disease.

Christensen DD, Lin P.

J Fam Pract. 2007 Dec;56(12 Suppl New):S17-23. Review.

PMID:
18664338
[PubMed - indexed for MEDLINE]
14.

Opportunities for improving managed care for individuals with dementia: Part 1--The issues.

Fillit H, Knopman D, Cummings J, Appel F.

Am J Manag Care. 1999 Mar;5(3):309-15.

PMID:
10351027
[PubMed - indexed for MEDLINE]
Free Article
15.

Methods of cost-effectiveness analysis in the assessment of new drugs for Alzheimer's disease.

Neumann PJ, Hermann RC, Berenbaum PA, Weinstein MC.

Psychiatr Serv. 1997 Nov;48(11):1440-4. Review.

PMID:
9355172
[PubMed - indexed for MEDLINE]
16.

[Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].

Sicras-Mainar A, Vergara J, Leon-Colombo T, Febrer L, Rejas-Gutierrez J.

Rev Neurol. 2006 Oct 16-31;43(8):449-53. Spanish.

PMID:
17033976
[PubMed - indexed for MEDLINE]
Free Article
17.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
[PubMed - indexed for MEDLINE]
18.

Evidence-based pharmacotherapy of Alzheimer's disease.

Evans JG, Wilcock G, Birks J.

Int J Neuropsychopharmacol. 2004 Sep;7(3):351-69. Epub 2004 Jul 1. Review.

PMID:
15228642
[PubMed - indexed for MEDLINE]
19.

NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.

Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES Jr, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M.

NIH Consens State Sci Statements. 2010 Apr 28;27(4):1-30. Review.

PMID:
20445638
[PubMed - indexed for MEDLINE]
Free Article
20.

Effective pharmacologic management of Alzheimer's disease.

Farlow MR, Cummings JL.

Am J Med. 2007 May;120(5):388-97. Review.

PMID:
17466645
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk